260 related articles for article (PubMed ID: 8668547)
1. Positively charged oligonucleotides overcome potassium-mediated inhibition of triplex DNA formation.
Dagle JM; Weeks DL
Nucleic Acids Res; 1996 Jun; 24(11):2143-9. PubMed ID: 8668547
[TBL] [Abstract][Full Text] [Related]
2. A new approach to overcome potassium-mediated inhibition of triplex formation.
Svinarchuk F; Cherny D; Debin A; Delain E; Malvy C
Nucleic Acids Res; 1996 Oct; 24(19):3858-65. PubMed ID: 8871568
[TBL] [Abstract][Full Text] [Related]
3. Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides.
Vasquez KM; Dagle JM; Weeks DL; Glazer PM
J Biol Chem; 2001 Oct; 276(42):38536-41. PubMed ID: 11504712
[TBL] [Abstract][Full Text] [Related]
4. Highly stable DNA triplexes formed with cationic phosphoramidate pyrimidine alpha-oligonucleotides.
Michel T; Debart F; Heitz F; Vasseur JJ
Chembiochem; 2005 Jul; 6(7):1254-62. PubMed ID: 15912553
[TBL] [Abstract][Full Text] [Related]
5. Stable and Selective Antiparallel Type Triplex DNA Formation by Targeting a GC Base Pair with the TFO Containing One N
Taniguchi Y; Miyazaki M; Matsueda N; Wang L; Okamura H; Sasaki S
Chem Pharm Bull (Tokyo); 2018; 66(6):624-631. PubMed ID: 29863064
[TBL] [Abstract][Full Text] [Related]
6. Promotion of stable triplex formation by partial incorporation of 2',5'-phosphodiester linkages into triplex-forming oligonucleotides.
Obika S; Hiroto A; Nakagawa O; Imanishi T
Chem Commun (Camb); 2005 Jun; (22):2793-5. PubMed ID: 15928760
[TBL] [Abstract][Full Text] [Related]
7. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C
Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028
[TBL] [Abstract][Full Text] [Related]
8. Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.
Rogers FA; Lloyd JA; Tiwari MK
Artif DNA PNA XNA; 2014; 5(1):e27792. PubMed ID: 25483840
[TBL] [Abstract][Full Text] [Related]
9. Triple helix formation with purine-rich phosphorothioate-containing oligonucleotides covalently linked to an acridine derivative.
Lacoste J; François JC; Hélène C
Nucleic Acids Res; 1997 May; 25(10):1991-8. PubMed ID: 9115367
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Cm/T, G/A, and G/T triplex stability by conjugate groups in the presence and absence of KCl.
Gamper HB; Kutyavin IV; Rhinehart RL; Lokhov SG; Reed MW; Meyer RB
Biochemistry; 1997 Dec; 36(48):14816-26. PubMed ID: 9398203
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter.
Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE
Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472
[TBL] [Abstract][Full Text] [Related]
12. Chemical modification of triplex-forming oligonucleotide to promote pyrimidine motif triplex formation at physiological pH.
Torigoe H; Nakagawa O; Imanishi T; Obika S; Sasaki K
Biochimie; 2012 Apr; 94(4):1032-40. PubMed ID: 22245184
[TBL] [Abstract][Full Text] [Related]
13. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
[TBL] [Abstract][Full Text] [Related]
14. Stable oligonucleotide-directed triplex formation at target sites with CG interruptions: strong sequence-specific recognition by 2',4'-bridged nucleic-acid-containing 2-pyridones under physiological conditions.
Obika S; Hari Y; Sekiguchi M; Imanishi T
Chemistry; 2002 Oct; 8(20):4796-802. PubMed ID: 12561120
[TBL] [Abstract][Full Text] [Related]
15. Triplex formation by morpholino oligodeoxyribonucleotides in the HER-2/neu promoter requires the pyrimidine motif.
Basye J; Trent JO; Gao D; Ebbinghaus SW
Nucleic Acids Res; 2001 Dec; 29(23):4873-80. PubMed ID: 11726697
[TBL] [Abstract][Full Text] [Related]
16. Effect of ENA modification of triplex-forming oligonucleotide on pyrimidine motif triplex formation.
Torigoe H; Nagasawa N
Nucleic Acids Symp Ser (Oxf); 2007; (51):161-2. PubMed ID: 18029636
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamic and kinetic effects of N3'-->P5' phosphoramidate modification on pyrimidine motif triplex DNA formation.
Torigoe H
Biochemistry; 2001 Jan; 40(4):1063-9. PubMed ID: 11170429
[TBL] [Abstract][Full Text] [Related]
18. Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA.
Campbell MA; Miller PS
Bioconjug Chem; 2009 Dec; 20(12):2222-30. PubMed ID: 19950917
[TBL] [Abstract][Full Text] [Related]
19. Poly(L-lysine)-graft-dextran copolymer: amazing effects on triplex stabilization under physiological pH and ionic conditions (in vitro).
Ferdous A; Watanabe H; Akaike T; Maruyama A
Nucleic Acids Res; 1998 Sep; 26(17):3949-54. PubMed ID: 9705503
[TBL] [Abstract][Full Text] [Related]
20. Effect of cations on purine.purine.pyrimidine triple helix formation in mixed-valence salt solutions.
Floris R; Scaggiante B; Manzini G; Quadrifoglio F; Xodo LE
Eur J Biochem; 1999 Mar; 260(3):801-9. PubMed ID: 10103010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
